August 11, 2026
From Palliative to Curative: FDA Approval of Enhertu Marks a Paradigm Shift in Early-Stage HER2-Positive Breast Cancer Treatment from-palliative-to-curative-fda-approval-of-enhertu-marks-a-paradigm-shift-in-early-stage-her2-positive-breast-cancer-treatment

From Palliative to Curative: FDA Approval of Enhertu Marks a Paradigm Shift in Early-Stage HER2-Positive Breast Cancer Treatment

Dwi Wanna June 22, 2026
The landscape of breast oncology underwent a seismic shift on May 15, as the U.S. Food and...
Read More Read more about From Palliative to Curative: FDA Approval of Enhertu Marks a Paradigm Shift in Early-Stage HER2-Positive Breast Cancer Treatment
A Collision of Fate: How an Unexpected Accident Led One International Student to Her Life-Saving Diagnosis a-collision-of-fate-how-an-unexpected-accident-led-one-international-student-to-her-life-saving-diagnosis

A Collision of Fate: How an Unexpected Accident Led One International Student to Her Life-Saving Diagnosis

Neng Nana June 22, 2026
In the fall of 2023, Joy, a 31-year-old international student from China, arrived in Columbia, South Carolina,...
Read More Read more about A Collision of Fate: How an Unexpected Accident Led One International Student to Her Life-Saving Diagnosis
A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma a-new-frontier-in-hematology-teclistamab-redefines-treatment-for-high-risk-smoldering-multiple-myeloma

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

Nila Kartika Wati June 22, 2026
In a landmark development for the field of hematology, researchers from the Dana-Farber Cancer Institute have unveiled...
Read More Read more about A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma
Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy beyond-the-initial-impact-the-convergence-of-tbi-and-alzheimers-research-and-the-promise-of-next-generation-immunotherapy

Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy

Neng Nana June 22, 2026
Traumatic Brain Injury (TBI) is often perceived as a singular event—a collision, a fall, or a strike....
Read More Read more about Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy

You may have missed

vaderis-therapeutics-secures-152-million-in-series-b-funding-to-advance-breakthrough-hht-treatment

Vaderis Therapeutics Secures $152 Million in Series B Funding to Advance Breakthrough HHT Treatment

Asro August 11, 2026
the-great-shift-understanding-the-2025-medicaid-work-requirement-mandate

The Great Shift: Understanding the 2025 Medicaid Work Requirement Mandate

Nila Kartika Wati August 11, 2026
the-gentle-path-why-passive-yoga-is-the-secret-to-unlocking-tight-hips

The Gentle Path: Why Passive Yoga is the Secret to Unlocking Tight Hips

Iffa Jayyana August 11, 2026
unraveling-the-nf-1-enigma-beyond-genes-a-new-frontier-in-understanding-tumor-growth

Unraveling the NF-1 Enigma: Beyond Genes, A New Frontier in Understanding Tumor Growth

Nana August 11, 2026